You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
巨星醫療控股(02393.HK)接獲傳訊令狀
格隆匯 04-17 08:12

格隆匯4月17日丨巨星醫療控股(02393.HK)發佈公吿,有關公司所發行本金額約為1.979億美元於2026年到期的9.5%優先票據。如此前公吿所披露,根據規管新票據的契約,公司於2022年12月30日或之前到期贖回新票據原本金額的5%。此外,新票據的利息已於2022年12月30日到期應付。根據規管新票據的契約,公司有30天的寬限期支付利息,惟寬限期已屆滿。於該公吿日期,公司並無贖回任何新票據,或償還利息。

麥迪森信託有限公司就新票據於香港特別行政區高等法院原訟法庭發出針對公司的傳訊令狀(訴訟編號:高等法院民事訴訟案件二零二三年第570號)。該令狀就(其中包括)下列各項提出申索:(a)支付約989.32萬美元,乃按相等於面值的贖回價,另加應計未付利息及就公司票據應計的半年利息計算,即約1.979億美元的至少5%的未償還付款;(b)支付923.91萬美元,即由2021年12月31日起至付款為止按年利率9.5%計算的利息;(c)限制公司(其中包括)召開股東特別大會及批准出售事項的強制令;(d)利息;(e)訟費;及(f)法院可能認為合適的其他濟助。

公司一直主動與新票據的主要持有人對話,以期探求及循潛在途徑解決流動資金問題並達成共識方案,以最佳方式保障其所有持份者的利益。監於最新發展,公司亦正就上述事項尋求法律意見。公司將於有需要時另行發表公吿。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account